abstract |
Use of a compound formula (I), (II), (III) or (IV) in the manufacture of a medicament for inhibiting activation of a hedgehog pathway in a cell or for inhibiting progression of basal cell carcinoma is disclosed, wherein the variables shown in these formulae are as defined in the specification. These compounds are suitable for the treatment of cancer. |